{"id":610,"date":"2025-10-10T14:51:35","date_gmt":"2025-10-10T12:51:35","guid":{"rendered":"https:\/\/nuklid.network\/news\/bad-prospects-for-cancer"},"modified":"2026-04-04T10:35:32","modified_gmt":"2026-04-04T08:35:32","slug":"bad-prospects-for-cancer","status":"publish","type":"post","link":"https:\/\/nuklid.network\/en\/news\/bad-prospects-for-cancer","title":{"rendered":"Bad prospects for cancer"},"content":{"rendered":"

Radiopharmaceuticals \"Made in Dresden-Rossendorf\": ROTOP continues to grow<\/strong><\/h2>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>

Jens Junker has been Managing Director of Rotop Pharmaka GmbH in Dresden since 2014. Previously, the Saxon spent 20 years as Managing Director for various mechanical engineering companies in the Czech Republic, Poland, China and the USA. Photo: Arvid M\u00fcller<\/strong><\/em><\/p><\/div><\/div>

The Dresden-based company Rotop Pharmaka<\/strong> is a prime example of the boom in radiopharmaceuticals. Rotop, which emerged from the former Central Institute for Nuclear Research, is now one of the world's leading manufacturers of radioactive pharmaceuticals for diagnostics and cancer therapy. Managing Director Jens Junker<\/strong> leads a rapidly growing team of over 200 employees and is planning to build two new production facilities for therapeutics - a unique project in Europe. With the support of investors such as Genui<\/strong>, SHS<\/strong> and the WMS Growth Fund Saxony<\/strong>, the company aims to significantly expand its capacities and produce over 100,000 patient doses per year in the long term.<\/h4>\n

Read the full article by Michael Rothe<\/strong> in Die Wirtschaft in Sachsen<\/em> from October 1, 2025<\/strong>.

<\/h4><\/div>
To the original article<\/span><\/div><\/div><\/a><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Radiopharmaceuticals “Made in Dresden-Rossendorf”: ROTOP continues to grow Jens Junker has been Managing Director of Rotop Pharmaka GmbH in Dresden since 2014. Previously, the Saxon spent 20 years as Managing Director for various mechanical engineering companies in the Czech Republic, Poland, China and the USA. Photo: Arvid M\u00fcllerThe Dresden-based company Rotop Pharmaka is a prime example of the boom in … <\/p>\n

Read More<\/a><\/div>\n","protected":false},"author":3,"featured_media":609,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-610","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-unkategorisiert"],"acf":[],"yoast_head":"\nBad prospects for cancer - nukliD\u00ae \u2013 Radiopharmacy Cluster Dresden<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nuklid.network\/en\/news\/bad-prospects-for-cancer\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bad prospects for cancer - nukliD\u00ae \u2013 Radiopharmacy Cluster Dresden\" \/>\n<meta property=\"og:description\" content=\"Radiopharmaceuticals "Made in Dresden-Rossendorf": ROTOP continues to grow Jens Junker has been Managing Director of Rotop Pharmaka GmbH in Dresden since 2014. Previously, the Saxon spent 20 years as Managing Director for various mechanical engineering companies in the Czech Republic, Poland, China and the USA. Photo: Arvid M\u00fcllerThe Dresden-based company Rotop Pharmaka is a prime example of the boom in ... Read More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nuklid.network\/en\/news\/bad-prospects-for-cancer\" \/>\n<meta property=\"og:site_name\" content=\"nukliD\u00ae \u2013 Radiopharmacy Cluster Dresden\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-10T12:51:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-04T08:35:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nuklid.network\/wp-content\/uploads\/SZD-AM-20250909-20886-1024x683-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Carola Graf\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Carola Graf\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nuklid.network\\\/en\\\/news\\\/bad-prospects-for-cancer#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nuklid.network\\\/en\\\/news\\\/bad-prospects-for-cancer\"},\"author\":{\"name\":\"Carola Graf\",\"@id\":\"https:\\\/\\\/nuklid.network\\\/en#\\\/schema\\\/person\\\/1262df3863ac7fdd716af7dd9758a0fe\"},\"headline\":\"Bad prospects for cancer\",\"datePublished\":\"2025-10-10T12:51:35+00:00\",\"dateModified\":\"2026-04-04T08:35:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nuklid.network\\\/en\\\/news\\\/bad-prospects-for-cancer\"},\"wordCount\":191,\"publisher\":{\"@id\":\"https:\\\/\\\/nuklid.network\\\/en#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nuklid.network\\\/en\\\/news\\\/bad-prospects-for-cancer#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nuklid.network\\\/wp-content\\\/uploads\\\/SZD-AM-20250909-20886-1024x683-1.jpg\",\"articleSection\":[\"Unkategorisiert\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nuklid.network\\\/en\\\/news\\\/bad-prospects-for-cancer\",\"url\":\"https:\\\/\\\/nuklid.network\\\/en\\\/news\\\/bad-prospects-for-cancer\",\"name\":\"Bad prospects for cancer - nukliD\u00ae \u2013 Radiopharmacy Cluster Dresden\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nuklid.network\\\/en#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nuklid.network\\\/en\\\/news\\\/bad-prospects-for-cancer#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nuklid.network\\\/en\\\/news\\\/bad-prospects-for-cancer#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nuklid.network\\\/wp-content\\\/uploads\\\/SZD-AM-20250909-20886-1024x683-1.jpg\",\"datePublished\":\"2025-10-10T12:51:35+00:00\",\"dateModified\":\"2026-04-04T08:35:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nuklid.network\\\/en\\\/news\\\/bad-prospects-for-cancer#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nuklid.network\\\/en\\\/news\\\/bad-prospects-for-cancer\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/nuklid.network\\\/en\\\/news\\\/bad-prospects-for-cancer#primaryimage\",\"url\":\"https:\\\/\\\/nuklid.network\\\/wp-content\\\/uploads\\\/SZD-AM-20250909-20886-1024x683-1.jpg\",\"contentUrl\":\"https:\\\/\\\/nuklid.network\\\/wp-content\\\/uploads\\\/SZD-AM-20250909-20886-1024x683-1.jpg\",\"width\":1024,\"height\":683,\"caption\":\"09.09.2025. FA WE. Jens Junker, head of Rotop Pharmaka GmbH at the Helmholtz Zentrum Dresden Rossendorf. Photo: Arvid Mueller - Free of charge for products of S\u00e4chsische.de and S\u00e4chsische Zeitung - ***LocalCaption***For editorial use only*** - Released for SZ\\\/saechsische.de - for further use clearing of personal rights by client\\\/user - \u00a9 Arvid Mueller - Industry & Press Photography, MOBIL: +491797866218, MAIL: kontakt@arvidmueller.de, WEB: www.arvidmueller.de. Use only for a fee, as well as Copyright attribution. Any commercial use is subject to a fee. Passing on to third parties only after prior agreement with the author. Presentation on the Internet is subject to a fee, also as a 1:1 copy in Internet editions of daily newspapers and magazines. Author's name also for Internet presentation according to \u00a713 Urh Ges. Any further use after the first print of the image material is also subject to a fee. The clarification of the personal, art or trademark rights lies with the user.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nuklid.network\\\/en\\\/news\\\/bad-prospects-for-cancer#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\",\"item\":\"https:\\\/\\\/nuklid.network\\\/en\\\/home-2\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bad prospects for cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nuklid.network\\\/en#website\",\"url\":\"https:\\\/\\\/nuklid.network\\\/en\",\"name\":\"nukliD \u2013 Radiopharmacy Cluster Dresden\",\"description\":\"Die Plattform f\u00fcr Radiopharmazie in Sachsen\",\"publisher\":{\"@id\":\"https:\\\/\\\/nuklid.network\\\/en#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nuklid.network\\\/en?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nuklid.network\\\/en#organization\",\"name\":\"nukliD \u2013 Radiopharmacy Cluster Dresden\",\"url\":\"https:\\\/\\\/nuklid.network\\\/en\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/nuklid.network\\\/en#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nuklid.network\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/nuklid_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/nuklid.network\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/nuklid_logo.jpg\",\"width\":529,\"height\":188,\"caption\":\"nukliD \u2013 Radiopharmacy Cluster Dresden\"},\"image\":{\"@id\":\"https:\\\/\\\/nuklid.network\\\/en#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/showcase\\\/nuklid-radiopharmacy-cluster-dresden\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nuklid.network\\\/en#\\\/schema\\\/person\\\/1262df3863ac7fdd716af7dd9758a0fe\",\"name\":\"Carola Graf\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/18188d5111c72389cbaf748fcee63fd52c055d5d3c4d1fb484db38a858930eb6?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/18188d5111c72389cbaf748fcee63fd52c055d5d3c4d1fb484db38a858930eb6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/18188d5111c72389cbaf748fcee63fd52c055d5d3c4d1fb484db38a858930eb6?s=96&d=mm&r=g\",\"caption\":\"Carola Graf\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bad prospects for cancer - nukliD\u00ae \u2013 Radiopharmacy Cluster Dresden","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nuklid.network\/en\/news\/bad-prospects-for-cancer","og_locale":"en_US","og_type":"article","og_title":"Bad prospects for cancer - nukliD\u00ae \u2013 Radiopharmacy Cluster Dresden","og_description":"Radiopharmaceuticals \"Made in Dresden-Rossendorf\": ROTOP continues to grow Jens Junker has been Managing Director of Rotop Pharmaka GmbH in Dresden since 2014. Previously, the Saxon spent 20 years as Managing Director for various mechanical engineering companies in the Czech Republic, Poland, China and the USA. Photo: Arvid M\u00fcllerThe Dresden-based company Rotop Pharmaka is a prime example of the boom in ... Read More","og_url":"https:\/\/nuklid.network\/en\/news\/bad-prospects-for-cancer","og_site_name":"nukliD\u00ae \u2013 Radiopharmacy Cluster Dresden","article_published_time":"2025-10-10T12:51:35+00:00","article_modified_time":"2026-04-04T08:35:32+00:00","og_image":[{"width":1024,"height":683,"url":"https:\/\/nuklid.network\/wp-content\/uploads\/SZD-AM-20250909-20886-1024x683-1.jpg","type":"image\/jpeg"}],"author":"Carola Graf","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Carola Graf","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nuklid.network\/en\/news\/bad-prospects-for-cancer#article","isPartOf":{"@id":"https:\/\/nuklid.network\/en\/news\/bad-prospects-for-cancer"},"author":{"name":"Carola Graf","@id":"https:\/\/nuklid.network\/en#\/schema\/person\/1262df3863ac7fdd716af7dd9758a0fe"},"headline":"Bad prospects for cancer","datePublished":"2025-10-10T12:51:35+00:00","dateModified":"2026-04-04T08:35:32+00:00","mainEntityOfPage":{"@id":"https:\/\/nuklid.network\/en\/news\/bad-prospects-for-cancer"},"wordCount":191,"publisher":{"@id":"https:\/\/nuklid.network\/en#organization"},"image":{"@id":"https:\/\/nuklid.network\/en\/news\/bad-prospects-for-cancer#primaryimage"},"thumbnailUrl":"https:\/\/nuklid.network\/wp-content\/uploads\/SZD-AM-20250909-20886-1024x683-1.jpg","articleSection":["Unkategorisiert"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/nuklid.network\/en\/news\/bad-prospects-for-cancer","url":"https:\/\/nuklid.network\/en\/news\/bad-prospects-for-cancer","name":"Bad prospects for cancer - nukliD\u00ae \u2013 Radiopharmacy Cluster Dresden","isPartOf":{"@id":"https:\/\/nuklid.network\/en#website"},"primaryImageOfPage":{"@id":"https:\/\/nuklid.network\/en\/news\/bad-prospects-for-cancer#primaryimage"},"image":{"@id":"https:\/\/nuklid.network\/en\/news\/bad-prospects-for-cancer#primaryimage"},"thumbnailUrl":"https:\/\/nuklid.network\/wp-content\/uploads\/SZD-AM-20250909-20886-1024x683-1.jpg","datePublished":"2025-10-10T12:51:35+00:00","dateModified":"2026-04-04T08:35:32+00:00","breadcrumb":{"@id":"https:\/\/nuklid.network\/en\/news\/bad-prospects-for-cancer#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nuklid.network\/en\/news\/bad-prospects-for-cancer"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nuklid.network\/en\/news\/bad-prospects-for-cancer#primaryimage","url":"https:\/\/nuklid.network\/wp-content\/uploads\/SZD-AM-20250909-20886-1024x683-1.jpg","contentUrl":"https:\/\/nuklid.network\/wp-content\/uploads\/SZD-AM-20250909-20886-1024x683-1.jpg","width":1024,"height":683,"caption":"09.09.2025. FA WE. Jens Junker, head of Rotop Pharmaka GmbH at the Helmholtz Zentrum Dresden Rossendorf. Photo: Arvid Mueller - Free of charge for products of S\u00e4chsische.de and S\u00e4chsische Zeitung - ***LocalCaption***For editorial use only*** - Released for SZ\/saechsische.de - for further use clearing of personal rights by client\/user - \u00a9 Arvid Mueller - Industry & Press Photography, MOBIL: +491797866218, MAIL: kontakt@arvidmueller.de, WEB: www.arvidmueller.de. Use only for a fee, as well as Copyright attribution. Any commercial use is subject to a fee. Passing on to third parties only after prior agreement with the author. Presentation on the Internet is subject to a fee, also as a 1:1 copy in Internet editions of daily newspapers and magazines. Author's name also for Internet presentation according to \u00a713 Urh Ges. Any further use after the first print of the image material is also subject to a fee. The clarification of the personal, art or trademark rights lies with the user."},{"@type":"BreadcrumbList","@id":"https:\/\/nuklid.network\/en\/news\/bad-prospects-for-cancer#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"","item":"https:\/\/nuklid.network\/en\/home-2"},{"@type":"ListItem","position":2,"name":"Bad prospects for cancer"}]},{"@type":"WebSite","@id":"https:\/\/nuklid.network\/en#website","url":"https:\/\/nuklid.network\/en","name":"nukliD \u2013 Radiopharmacy Cluster Dresden","description":"Die Plattform f\u00fcr Radiopharmazie in Sachsen","publisher":{"@id":"https:\/\/nuklid.network\/en#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nuklid.network\/en?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/nuklid.network\/en#organization","name":"nukliD \u2013 Radiopharmacy Cluster Dresden","url":"https:\/\/nuklid.network\/en","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nuklid.network\/en#\/schema\/logo\/image\/","url":"https:\/\/nuklid.network\/wp-content\/uploads\/2024\/12\/nuklid_logo.jpg","contentUrl":"https:\/\/nuklid.network\/wp-content\/uploads\/2024\/12\/nuklid_logo.jpg","width":529,"height":188,"caption":"nukliD \u2013 Radiopharmacy Cluster Dresden"},"image":{"@id":"https:\/\/nuklid.network\/en#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/showcase\/nuklid-radiopharmacy-cluster-dresden\/"]},{"@type":"Person","@id":"https:\/\/nuklid.network\/en#\/schema\/person\/1262df3863ac7fdd716af7dd9758a0fe","name":"Carola Graf","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/18188d5111c72389cbaf748fcee63fd52c055d5d3c4d1fb484db38a858930eb6?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/18188d5111c72389cbaf748fcee63fd52c055d5d3c4d1fb484db38a858930eb6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/18188d5111c72389cbaf748fcee63fd52c055d5d3c4d1fb484db38a858930eb6?s=96&d=mm&r=g","caption":"Carola Graf"}}]}},"_links":{"self":[{"href":"https:\/\/nuklid.network\/en\/wp-json\/wp\/v2\/posts\/610","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nuklid.network\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nuklid.network\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nuklid.network\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/nuklid.network\/en\/wp-json\/wp\/v2\/comments?post=610"}],"version-history":[{"count":2,"href":"https:\/\/nuklid.network\/en\/wp-json\/wp\/v2\/posts\/610\/revisions"}],"predecessor-version":[{"id":859,"href":"https:\/\/nuklid.network\/en\/wp-json\/wp\/v2\/posts\/610\/revisions\/859"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nuklid.network\/en\/wp-json\/wp\/v2\/media\/609"}],"wp:attachment":[{"href":"https:\/\/nuklid.network\/en\/wp-json\/wp\/v2\/media?parent=610"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nuklid.network\/en\/wp-json\/wp\/v2\/categories?post=610"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nuklid.network\/en\/wp-json\/wp\/v2\/tags?post=610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}